Comparing Cancer Rates for Hepatitis C Patients to Those with No Cancer

Video

There are medications which can all but cure hepatitis C but for those patients who have not yet beaten the condition there is research that shows a link to developing cancer.

There are medications which can all but cure hepatitis C but for those patients who have not yet beaten the condition there is research that shows a link to developing cancer.

Anders Nyberg, MD, from Kaiser Permanente Medical Center discussed this health concern during Digestive Disease Week in Washington, DC. Nyberg said one of the biggest surprises in the research presented is how prevalent liver cancer was in these patients. He noted the rate was almost 70 times more for these patients proving how important it is to prevent cirrhosis before it becomes an even greater problem.

Recent Videos
Arshad Khanani, MD: Four-Year Outcomes of Faricimab for DME in RHONE-X | Image Credit: Sierra Eye Associates
Dilraj Grewal, MD: Development of MNV in Eyes with Geographic Atrophy in GATHER | Image Credit: Duke Eye Center
Margaret Chang, MD: Two-Year Outcomes of the PDS for Diabetic Retinopathy | Image Credit: Retina Consultants Medical Group
Carl C. Awh, MD: | Image Credit:
Raj K. Maturi, MD: 4D-150 for nAMD in PRISM Population Extension Cohort | Image Credit: Retina Partners Midwest
Charles C. Wykoff, MD, PhD: Interim Analysis on Ixo-Vec Gene Therapy for nAMD | Image Credit: Retina Consultants of Texas
Sunir J. Garg, MD: Pegcetacoplan Preserves Visual Function on Microperimetry | Image Credit: Wills Eye Hospital
Edward H. Wood, MD: Pharmacodynamics of Subretinal RGX-314 for Wet AMD | Image Credit: Austin Retina Associates
Dilsher Dhoot, MD: OTX-TKI for NPDR in Interim Phase 1 HELIOS Results  | Image Credit: LinkedIn
Katherine Talcott, MD: Baseline EZ Integrity Features Predict GA Progression | Image Credit: LinkedIn
© 2024 MJH Life Sciences

All rights reserved.